Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-13 Sale | 2023-06-15 9:01 pm | Replimune Group Inc. | REPL | Lewis Tanya Chief Dev. Op. Officer | 12,860 | $24.06 | $309,395 | 135,293 (Direct) | View |
| 2023-05-16 Sale | 2023-05-18 8:34 pm | Replimune Group Inc. | REPL | Lewis Tanya Chief Dev. Op. Officer | 12,207 | $18.05 | $220,336 | 148,153 (Direct) | View |
| 2022-05-16 Sale | 2022-05-18 7:02 pm | Replimune Group Inc. | REPL | Lewis Tanya Chief Dev. Op Officer | 5,473 | $14.59 | $79,851 | 120,360 (Direct) | View |
| 2021-02-11 Sale | 2021-02-17 6:49 pm | Karyopharm Therapeutics Inc. | KPTI | Lewis Tanya EVP, Chief Reg. Affairs | 2,046 | $15.52 | $31,752 | 4,143 (Direct) | View |
| 2020-10-30 Sale | 2020-11-04 8:18 pm | Karyopharm Therapeutics Inc. | KPTI | Lewis Tanya EVP,Chief Reg.&Quality Officer | 226 | $15.58 | $3,521 | 2,834 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-01 Option Award | 2024-06-03 4:14 pm | N/A 2034-05-31 | DiaMedica Therapeutics Inc. | DMAC | Lewis Tanya Director | 28,472 | $0 | 28,472 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:13 pm | N/A 2033-05-31 | DiaMedica Therapeutics Inc. | DMAC | Lewis Tanya Director | 7,493 | $0 | 7,493 (Direct) | View |
| 2023-04-01 Option Award | 2023-04-04 8:01 pm | N/A 2033-04-01 | Replimune Group Inc. | REPL | Lewis Tanya Chief Dev. Op. Officer | 100,000 | $0 | 220,360 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-06 5:14 pm | N/A 2033-02-28 | DiaMedica Therapeutics Inc. | DMAC | Lewis Tanya Director | 26,443 | $0 | 26,443 (Direct) | View |
Ownership | 2023-03-06 5:06 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Lewis Tanya Director | 0 | $0 | 0 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 4:15 pm | N/A 2032-04-01 | Replimune Group Inc. | REPL | Lewis Tanya Chief Dev.Op Off | 131,250 | $0 | 204,583 (Direct) | View |
| 2021-05-10 Option Award | 2021-05-11 9:01 pm | N/A 2031-05-10 | Replimune Group Inc. | REPL | Lewis Tanya Chief Dev. Oper. Off. | 183,333 | $0 | 183,333 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-05 8:14 pm | N/A 2031-04-01 | Replimune Group Inc. | REPL | Lewis Tanya Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 8:13 pm | N/A 2031-02-24 | Karyopharm Therapeutics Inc. | KPTI | Lewis Tanya EVP, Chief Reg. Affairs | 81,981 | $0 | 105,369 (Direct) | View |
| 2021-02-05 Exercise | 2021-02-09 8:34 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Lewis Tanya EVP, Chief Reg. Affairs | 5,650 | $0 | 23,139 (Direct) | View |
| 2020-10-28 Exercise | 2020-11-04 8:18 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Lewis Tanya EVP,Chief Reg.&Quality Officer | 765 | $0 | 2,834 (Direct) | View |
| 2020-11-02 Option Award | 2020-11-03 4:07 pm | N/A 2030-11-02 | Replimune Group Inc. | REPL | Lewis Tanya Director | 33,000 | $0 | 33,000 (Direct) | View |
| 2020-02-05 Option Award | 2020-02-07 4:21 pm | N/A 2030-02-04 | Karyopharm Therapeutics Inc. | KPTI | Lewis Tanya EVP,Chief Reg.&Quality Officer | 83,200 | $0 | 83,200 (Direct) | View |